Literature DB >> 18535075

Commentary: controversies in NICE guidance on management of type 2 diabetes.

Stephen Atkin1, Christopher Walton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535075      PMCID: PMC2413391          DOI: 10.1136/bmj.39581.495069.AD

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Safety of very tight blood glucose control in type 2 diabetes.

Authors:  Philip Home
Journal:  BMJ       Date:  2008-03-01

2.  Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Robert J Heine; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Authors:  Rury R Holman; Kerensa I Thorne; Andrew J Farmer; Melanie J Davies; Joanne F Keenan; Sanjoy Paul; Jonathan C Levy
Journal:  N Engl J Med       Date:  2007-09-21       Impact factor: 91.245

4.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 5.  Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Authors:  K Horvath; K Jeitler; A Berghold; S H Ebrahim; T W Gratzer; J Plank; T Kaiser; T R Pieber; A Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.